References
- De Gramont A, Watson S, Ellis LM, et al. Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nat Rev Clin Oncol Internet. 2015;12:197–212. Available from: http://www.nature.com/doifinder/10.1038/nrclinonc.2014.202
- Ternès N, Arnedos M, Koscielny S, et al. Statistical methods applied to omics data: predicting response to neoadjuvant therapy in breast cancer. Curr Opin Oncol. Internet. 2014; 26(6): 576–583. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25210869
- Singal AG, Zhang P, Waljee AK,et al. Body composition features predict overall survival in patients with hepatocellular carcinoma. Clin Transl Gastroenterol. 2016; 7(4): e172. Doi: 10.1038/ctg.2016.31.
- Krishnamurthy V, Zhang P, Ethiraj S,et al. Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk for cirrhosis. Clin Gastroenterol Hepatol. 2015; 13(2): 360–368.e5. Doi: 10.1016/j.cgh.2014.07.042
- Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol Internet. 2011;12:489–495. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21296615
- Lee -JS-J, He K, Harbaugh CM, et al. Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg Internet. 2011;53:912–917. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21215580
- Antoun S, Lanoy E, Iacovelli R, et al. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies. Cancer Internet. 2013;119:3377–3384. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23801109
- Antoun S, Bayar A, Ileana E, et al. High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting. Eur J Cancer. 2015;51(17):2570–2577.
- Chemama S, Bayar MA, Lanoy E, et al. Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2016. Internet Available from: http://link.springer.com/10.1245/s10434-016-5360-7
- Massicotte M-H-H, Borget I, Broutin S, et al. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. J Clin Endocrinol Metab Internet. 2013;98:2401–2408. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23543666
- Cousin S, Hollebecque A, Koscielny S, et al. Low skeletal muscle is associated with toxicity in patients included in phase I trials. Invest New Drugs. 2014;32(2):382–387.
- Malietzis G, Currie AC, Johns N, et al. Skeletal muscle changes after elective colorectal cancer resection: a longitudinal study. Ann Surg Oncol. Internet. December 2015 2016; 2539–2547. Available from: http://link.springer.com/10.1245/s10434-016-5188-1
- Ali R, Baracos VE, Sawyer MB, et al. Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens. Cancer Med Internet. 2016;5:607–616. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4831278&tool=pmcentrez&rendertype=abstract
- Jung H-W, Kim JHJ-YJW, Kim JHJ-YJW, et al. Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer Internet. 2015;23:687–694. Available from: http://link.springer.com/10.1007/s00520-014-2418-6
- Arrieta O, De La Torre-Vallejo M, Lopez-Macias D, et al. Nutritional status, body surface, and low lean body mass/body mass index are related to dose reduction and severe gastrointestinal toxicity induced by afatinib in patients with non-small cell lung cancer. Oncologist. 2015;20(8):967–974.
- Sjøblom B, Grønberg BH, Benth JŠ, et al. Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Lung Cancer. 2015;90(1):85–91.
- Cooper AB, Slack R, Fogelman D, et al. Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Ann Surg Oncol Internet. 2015;22:2416–2423. Available from: http://www.springerlink.com/%5Cnhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=2014979775
- Blauwhoff-Buskermolen S, Versteeg KS, De Van Der Schueren MAE, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol Internet. 2016;34:1339–1344. Available from: http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.6043%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/26903572
- Awad S, Tan BH, Cui H,et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 2012; 31(1): 74–77. Internet. 10.1016/j.clnu.2011.08.008 Available from.
- Gu WJ, Zhu Y, Wang HK, et al. Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series. Plos One. 2015;10(2):1–11.
- Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol Internet. 2013;31:1539–1547. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23530101
- Fujiwara N, Nakagawa H, Kudo Y,et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015; 63(1): 131–140. Internet. 10.1016/j.jhep.2015.02.031 Available from.
- Ishikawa J, Haimoto H, Hoshide S, et al. An increased visceral-subcutaneous adipose tissue ratio is associated with difficult-to-treat hypertension in men. J Hypertens Internet. 2010;28:1340–1346. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20467268
- Shen W. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. Internet. 2004; 97(6): 2333–2338. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15310748
- Aubrey J, Esfandiari N, Baracos VE, et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol. 2014;210(3):489–497.
- Adamek M, Heymsfield SB, Gonzalez MC, et al. Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle. Internet. 2014; 5(1): 9–18. Available from: http://doi.wiley.com/10.1007/s13539-014-0130-5
- Baracos VE, Reiman T, Mourtzakis M, et al. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. Internet. 2010; 91(4): 1133S–1137S. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20164322
- Wang SC, Holcombe SA, Derstine BA, et al. Reference analytic morphomics population (RAMP): a reference to measure occupant variability for crash injury analysis [Internet]. In: 2016 IRCOBI Conference Proceedings - International Research Council on the Biomechanics of Injury. International Research Council on the Biomechanics of Injury, 582–591 (2016) [cited 2017 Jan 30]. Available from: https://experts.umich.edu/en/publications/reference-analytic-morphomics-population-ramp-a-reference-to-meas.
- Stokes ME, Davis CS, Koch GG. Categorical data analysis using SAS 3rd. Cary, North Carolina:SAS institute; 2012.
- Littell RC, Milliken GA, Stroup WW, et al. SAS for Mixed Models 2nd. Cary, North Carolina: SAS institute; 2006.
- Putter H The landmark approach: an introduction and application to dynamic prediction in competing risks [Internet]. In: Proceedings of dynamic prediction for repeated markers and repeated events: models and validation in cancer workshop, Bordeaux (France), 2013, 2013. Available from: http://www.canceropole-gso.org/download/fichiers/2777/4_Putter.pdf.
- Van Houwelingen HC, Putter H. Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data. Lifetime Data Anal. 2008;14(4 SPEC. ISS):447–463.
- Peterson MD, Zhang P, Duchowny KA, et al. Declines in strength and mortality risk among older Mexican Americans: joint modeling of survival and longitudinal data. J Gerontol Ser Biol Sci Med Sci. Internet. 2016; 71(12): 1646–1652. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27013398
- Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.
- Cruz-Ramírez N, Acosta-Mesa HG, Carrillo-Calvet H, et al. Diagnosis of breast cancer using Bayesian networks: a case study. Comput Biol Med. Internet. 2007; 37(11): 1553–1564. Available from: www.intl.elsevierhealth.com/journals/cobm
- Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser Biol Sci Med Sci Internet. 2014;69:547–558. Available from: https://academic.oup.com/biomedgerontology/article-lookup/doi/10.1093/gerona/glu010
- Temel JS, Abernethy AP, Currow DC, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol Internet. 2016;17:519–531. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1470204515005586
- Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med. Internet. 2013; 4(2): 627–635. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24009950
- Antoun S, Baracos VE, Birdsell L, et al. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol. 2010;21(8):1594–1598.
- Lieffers JR, Bathe OF, Fassbender K, et al. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107(6):931–936. Internet. 10.1038/bjc.2012.350 Available from.
- Psutka SP, Carrasco A, Schmit GD, et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014;120(18):2910–2918.
- Peng PD, Van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. Hpb. 2011;13(7):439–446.
- Van Vugt JLA, Braam HJ, Van Oudheusden TR, et al. Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol Internet. 2015;22:3625–3631. Available from: http://www.springerlink.com/%5Cnhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=2015746441
- Huang DD, Wang SL, Zhuang CL, et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Color Dis. 2015;17(11):O256–O264.
- Sabel MS, Terjimanian M, Conlon ASC, et al. Analytic morphometric assessment of patients undergoing colectomy for colon cancer. J Surg Oncol. 2013;108(3):169–175.
- Joglekar S, Asghar A, Mott SL, et al. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol. 2015;111(6):771–775.
- Prado CMM, Birdsell LA, Baracos VE. The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliat Care. Internet. 2009; 3(4): 269–275. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19667996
- Jung B, Nougaret S, Conseil M, et al. Sepsis is associated with a preferential diaphragmatic atrophy: a critically ill patient study using tridimensional computed tomography. Anesthesiology Internet. 2014;120:1182–1191. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24608360
- Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst. Internet. 2010; 102(6): 365–367. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20208016
- Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. Internet. 2011; 60(3): 397–411. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21036793
- Ogino S, Nishihara R, VanderWeele TJ, et al. Review article: the role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology Internet. 2016;27:602–611. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001648-201607000-00022